Summit Securities Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 1335 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1002 |
|
|
2024
Q3 | – | Sell |
-816
| Closed | -$56K | – | 806 |
|
|
2024
Q2 | $56K | Buy |
+816
| New | +$56K | 0.01% | 184 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 964 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 555 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 283 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 306 |
|
|
2019
Q3 | – | Sell |
-45,735
| Closed | -$594K | – | 245 |
|
|
2019
Q2 | $594K | Buy |
+45,735
| New | +$594K | 0.07% | 62 |
|